Trending Tickers : Halliburton Company (NYSE:HAL), ArcelorMittal SA (ADR) (NYSE:MT), Columbia Property Trust, Inc. (NYSE:CXP), Coherent Inc. (NASDAQ:COHR), Endocyte, Inc. (NASDAQ:ECYT)

Technology Stocks News 13

On Oct 21, As fracking accelerates in North American shale fields, oilfield services providers Halliburton Company (NYSE:HAL) and Baker Hughes Inc are stockpiling sand to protect themselves against rising costs and are buying more railcars to transport the haul. Halliburton Company (NYSE:HAL) belongs to Basic Materials sector. Its net profit margin is 10.70% and weekly performance is -1.00%. On last trading day company shares ended up $52.39. Halliburton Company (NYSE:HAL) distance from 50-day simple moving average (SMA50) is -16.79%.

On October 23, ArcelorMittal SA (ADR) (NYSE:MT) announces the publication of sell-side analysts’ consensus forecasts for ArcelorMittal’s third quarter 2014 Ebitda. ArcelorMittal SA (ADR) (NYSE:MT) shares moved down -2.70% in last trading session and ended the day at $12.59. MT return on assets is -1.50%. ArcelorMittal SA (ADR) (NYSE:MT) quarterly performance is -17.33%.

Columbia Property Trust (NYSE:CXP) Director John L. Dixon acquired 2,000 shares of the stock in a transaction dated Monday, September 15th. The shares were purchased at an average price of $25.07 per share, with a total value of $50,140.00. On 27 October, Columbia Property Trust, Inc. (NYSE:CXP) shares advanced 0.59% and was closed at $25.43. CXP EPS growth in last 5 year was 23.10%. Columbia Property Trust, Inc. (NYSE:CXP) year to date (YTD) performance is 5.30%.

On Oct. 16, Coherent Inc. (NASDAQ:COHR) announced that it plans to report its fourth quarter and fiscal year 2014 financial results after market close on November 4, 2014. Coherent Inc. (NASDAQ:COHR) ended the last trading day at $59.74. Company weekly volatility is calculated as 2.92% and price to cash ratio as 4.91. Coherent Inc. (NASDAQ:COHR) showed a weekly performance of 1.84%.

Citigroup Inc. restated their neutral rating on shares of Endocyte (NASDAQ:ECYT) in a report released on Monday. Citigroup Inc. currently has a $10.00 price objective on the stock, up from their previous price objective of $8.00. Endocyte, Inc. (NASDAQ:ECYT) shares advanced 0.52% in last trading session and ended the day at $5.84. ECYT return on assets is 7.50%. Endocyte, Inc. (NASDAQ:ECYT) quarterly performance is -4.58%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone